Surita Dalal

Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease

Talha Munir, David A. Cairns, Adrian Bloor et al. · New England Journal of Medicine · 2023 · 155 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Vascular Endothelial Growth Factor: A Therapeutic Target for Tumors of the Ewing's Sarcoma Family

Surita Dalal, Andrea M. Berry, Catherine J Cullinane et al. · Clinical Cancer Research · 2005 · 117 citations

Medicine, Cancer Biology, Oncology +17

Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial

Peter Hillmen, Alexandra Pitchford, Adrian Bloor et al. · The Lancet Oncology · 2023 · 106 citations · Full text

Medicine, Immunology, Pharmacotherapy +14

Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLL

Marwan Kwok, Ceri Oldreive, Andy C. Rawstron et al. · Blood · 2019 · 28 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia

Talha Munir, Sean Girvan, David A. Cairns et al. · New England Journal of Medicine · 2025 · 28 citations · Full text

Medicine, Hematology, Oncology +15